Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
Jean‐François Emile(Inserm), Yves Humblet(Deventer Ziekenhuis), Robert Steinacher, Josep Tabernero(Deaconess Hospital), Ghislain Houbiers, Joseph Kerger(Institut Jules Bordet), Ewald Woell, Gunnar Folprecht, Jean‐Luc Van Laethem(Deventer Ziekenhuis), Julien Taı̈eb(Hôpital Européen Georges-Pompidou), Marc Peeters(University of Antwerp), Camille Boulagnon‐Rombi(Centre Hospitalier Universitaire de Reims), Karine Le Malicot(Inserm), Johannes Gaenzer, Jaafar Bennouna(Hôpital Foch), A. Lenauer, Guido Deboever, Côme Lepage(Inserm), Thierry Delaunoit, Alois Lang(Landeskrankenhaus Feldkirch), Richard Greil(Paracelsus Medical University), Franz A. Schmid(Alfred-Wegener-Institut Helmholtz-Zentrum für Polar- und Meeresforschung), Enrico Mini(University of Florence), Hassan Rezaie Kalantari(Institute of Pharmacology), Philippe Vergauwe, Geert D’Haens(Amsterdam University Medical Centers), Wolfgang Eisterer(Klinikum Klagenfurt), Marc Polus, Michael Fridrik, R. Függer(Johannes Kepler University of Linz), Gauthier Demolin, Marc‐Antoine Allard(Assistance Publique – Hôpitaux de Paris), August Zabernigg, Pierre Laurent‐Puig(Inserm), Eric Van Cutsem(Universitair Ziekenhuis Leuven), Gilbert Ghillebert(Institut des Sciences Moléculaires de Marseille), Felix Keil(Hanusch Hospital), Hellmut Samonigg(Graz University Hospital), Johannes Andel(Engineering Software Steyr (Austria)), Günther Steger(Barwon Health), D. Geißler(Klinikum Klagenfurt), Manfred Prager, J. Thaler(Klinikum Wels-Grieskirchen), Catherine Julié(Université Paris-Saclay), Frédérique Penault–Llorca(Inserm), Jean Charles. Goeminne, F Hofbauer, Stéphanie Dimet(Roche (France)), Björn Jagdt(Institut de Cancérologie de l'Ouest)
Cited by 47
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k